CASTLE BIOSCIENCES, INC.
505 S. Friendswood Drive, Suite 401
Friendswood, Texas 77546
April 12, 2024
Division of Corporation Finance
Office of Trade & Services
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
| RE: | Castle Biosciences, Inc. |
Registration Statement on Form S-3
File No. 333-277470
Ladies and Gentlemen:
Castle Biosciences, Inc. (the “Registrant”) hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-277470) to become effective on Tuesday, April 16, 2024, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes Carlos Ramirez of Cooley LLP, counsel to the Registrant, to make such request on its behalf.
Once the Registration Statement has been declared effective, please orally confirm that event with Carlos Ramirez of Cooley LLP, counsel to the Registrant, at (858) 550-6157 or, in his absence, Thomas Coll at (858) 550-6013 or Sarah Curry at (212) 479-6652.
[remainder of page intentionally left blank]
| Very truly yours, | ||
| CASTLE BIOSCIENCES, INC. | ||
| By: | /s/ Derek J. Maetzold | |
| Name: | Derek J. Maetzold | |
| Title: | President and Chief Executive Officer | |
| cc: | Carlos Ramirez, Cooley LLP |
Thomas Coll, Cooley LLP
Sarah Curry, Cooley LLP